comparemela.com
Latest Breaking News On - Piccolic dichloroacetate - Page 1 : comparemela.com
Saol Therapeutics enhances its IP portfolio for Dichloroacetate (DCA; SL-1009) in Glioblastoma and Rare Pediatric Cancers
/PRNewswire/ Saol Therapeutics ("Saol"), a privately held, clinical-stage pharmaceutical company, announced today the signing of an agreement with Medosome.
Ireland
Dublin
Bermuda
Biochim-biophys-acta
Medosome-biotec
David-penake
Piccolic-dichloroacetate
Virinder-nohria
Brian-nappi
Professor-of-medicine-at-university-florida
Ann-clin-lab-sci
University-of-florida
vimarsana © 2020. All Rights Reserved.